HEMZERTA
Pharmaceutical products, namely, recombinant antihemophilic factor preparations, blood clotting factor concentrates, coagulation factor preparations and other hemostatic agents for the treatment of hemophilia
Abandoned · December 4, 2012 · 85793800 ·